To determine the seroprevalence of human herpesvirus 8 (HHV8) among human immunodeficiency virus 1 (HIV-1)-positive (HIV-1 + ) and HIV-1-negative (HIV-1 -) populations in Japan, 276 HIV-1 + patients and 1,000 HIV-1 -blood donors were enrolled in this study. Antibodies against HHV8 latency-associated
Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human Immunodeficiency virus-1-infected patients
โ Scribed by J.C. Leao; N. Kumar; K.A. McLean; S.R. Porter; C.M. Scully; A.V. Swan; C.G. Teo
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 98 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Human herpesvirus 8 (HHV-8) is believed to play a role in the pathogenesis of Kaposi's sarcoma (KS) and possibly in other proliferative disorders often associated with human immunodeficiency virus type 1 (HIV-1) infection. Recent case reports have indicated resolution of KS and clearance of HHV-8 DN
By bioactive-guided fractionation of a water extract of Cordia spinescens, magnesium lithospermate (1), calcium rosmarinate (2) and magnesium rosmarinate (3) were isolated as potent inhibitory substances against HIV-1 reverse transcriptase (RT) with IC 50 values of 0.8, 5.8 and 3.1 M, respectively.